303 related articles for article (PubMed ID: 29809231)
1. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
[TBL] [Abstract][Full Text] [Related]
2. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
[TBL] [Abstract][Full Text] [Related]
4. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
5. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study.
Lillig R; Ophey A; Schulz JB; Reetz K; Wojtala J; Storch A; Liepelt-Scarfone I; Becker S; Berg D; Balzer-Geldsetzer M; Kassubek J; Hilker-Roggendorf R; Witt K; Mollenhauer B; Trenkwalder C; Roeske S; Wittchen HU; Riedel O; Dodel R; Kalbe E
Parkinsonism Relat Disord; 2021 Sep; 90():90-97. PubMed ID: 34418761
[TBL] [Abstract][Full Text] [Related]
6. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
Souza CP; Oliveira GN; Foss MP; Tumas V
J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
[TBL] [Abstract][Full Text] [Related]
8. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease.
Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K
Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524
[TBL] [Abstract][Full Text] [Related]
9. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the cognitive items of the movement disorders society checklist for the diagnosis of dementia in patients with Parkinson's disease.
Oliveira GN; Souza CP; Foss MP; Tumas V
Parkinsonism Relat Disord; 2015 Oct; 21(10):1260-3. PubMed ID: 26289825
[TBL] [Abstract][Full Text] [Related]
11. Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT).
Beck IR; Gagneux-Zurbriggen A; Berres M; Taylor KI; Monsch AU
Arch Clin Neuropsychol; 2012 Aug; 27(5):510-9. PubMed ID: 22718104
[TBL] [Abstract][Full Text] [Related]
12. CERAD-neuropsychological battery in screening mild Alzheimer's disease.
Sotaniemi M; Pulliainen V; Hokkanen L; Pirttilä T; Hallikainen I; Soininen H; Hänninen T
Acta Neurol Scand; 2012 Jan; 125(1):16-23. PubMed ID: 21198445
[TBL] [Abstract][Full Text] [Related]
13. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C
Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580
[TBL] [Abstract][Full Text] [Related]
16. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
Barth S; Schönknecht P; Pantel J; Schröder J
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
[TBL] [Abstract][Full Text] [Related]
17. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
[TBL] [Abstract][Full Text] [Related]
19. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.
Smith CR; Cullen B; Sheridan MP; Cavanagh J; Grosset KA; Grosset DG
Acta Neurol Scand; 2020 Jun; 141(6):500-508. PubMed ID: 32002988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
